Post-Progression Treatment Eligibility of Unresectable Hepatocellular Carcinoma Patients Treated with Lenvatinib-Reference-Cited by-同舟云学术

Post-Progression Treatment Eligibility of Unresectable Hepatocellular Carcinoma Patients Treated with Lenvatinib

Published:2019-10-18 Issue:1 Volume:9 Page:73-83
ISSN:2235-1795
Container-title:Liver Cancer
language:en
Short-container-title:Liver Cancer

Author:

Hiraoka Atsushi^ORCID,Kumada Takashi,Fukunishi Shinya,Atsukawa Masanori,Hirooka Masashi,Tsuji Kunihiko,Ishikawa Toru,Takaguchi Koichi,Kariyama Kazuya,Itobayashi Ei,Tajiri Kazuto,Shimada Noritomo,Shibata Hiroshi,Ochi Hironori,Tada Toshifumi,Toyoda Hidenori,Yokohama Keisuke,Nouso Kazuhiro,Tsutsui Akemi,Nagano Takuya,Itokawa Norio,Hayama Korenobu,Arai Taeang,Imai Michitaka,Joko Kouji,Koizumi Yohei,Hiasa Yoichi,Michitaka Kojiro,Kudo Masatoshi,

Publisher

S. Karger AG

Subject

Oncology,Hepatology

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early Changes in Alpha-Fetoprotein and Des-γ-Carboxy Prothrombin Are Useful Predictors of Antitumor Response to Durvalumab Plus Tremelimumab Therapy for Advanced Hepatocellular Carcinoma;Current Oncology;2024-07-26

2. Establishment and Internal Validation of a Prognostic Score for Post-hepatectomy Liver Failure Based on Functional Liver Parameters Estimated via TC-99m GSA;Cureus;2023-07-22

3. Lenvatinib Induces Immunogenic Cell Death and Triggers Toll-Like Receptor-3/4 Ligands in Hepatocellular Carcinoma;Journal of Hepatocellular Carcinoma;2023-04

4. Effects of Lenvatinib on Skeletal Muscle Volume and Cardiac Function in Patients with Hepatocellular Carcinoma;Oncology;2023

5. Impact of Post-progression Survival on Outcomes of Lenvatinib Treatment for Unresectable Hepatocellular Carcinoma: A Systematic Review and Retrospective Cohort Study;Anticancer Research;2022-12